Management

Jaisim Shah is a successful life science leader with significant success in global business development and product commercialization. Jaisim’s track record of success in leading teams in the commercialization of some of today’s most recognized pharmaceutical brands. Innovation, collaboration and patient care has been at the heart and soul of his extensive life science career… read more »

Suketu D. Desai, Ph.D. has 25+ years of experience in the Biologics and Pharmaceutical Industry. Suketu is Chief Technical Officer and Senior Vice President, Chemistry, Manufacturing and Controls, Regulatory CMC and Quality at Semnur Pharmaceuticals (acquired by Scilex Pharmaceuticals), Inc., (2015-current). Prior to Semnur, Suketu was Vice President of Biologics Development and Manufacturing for biologics… read more »

Dmitri Lissin currently serves as Chief Medical Officer and Senior Vice President, Clinical Development and Medical Affairs of Scilex/Semnur Pharmaceuticals. Prior to Semnur, from 2011-2015, Dmitri was Vice President of Clinical Development at Xenoport, responsible for conduct of multiple clinical research programs in neurology and dermatology. From 2006-2011 Dmitri directed a clinical research team and… read more »